HomeAVTE • NASDAQ
add
Aerovate Therapeutics Inc
Previous close
$2.43
Day range
$2.39 - $2.45
Year range
$1.25 - $32.42
Market cap
69.30M USD
Avg Volume
139.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.40M | -70.98% |
Net income | -5.43M | 73.40% |
Net profit margin | — | — |
Earnings per share | -0.19 | 74.32% |
EBITDA | -6.40M | 70.98% |
Effective tax rate | -1.02% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 78.62M | -35.79% |
Total assets | 80.33M | -36.95% |
Total liabilities | 3.90M | -78.30% |
Total equity | 76.43M | — |
Shares outstanding | 28.99M | — |
Price to book | 0.92 | — |
Return on assets | -18.69% | — |
Return on capital | -20.28% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.43M | 73.40% |
Cash from operations | -11.05M | 25.36% |
Cash from investing | 13.13M | 132.45% |
Cash from financing | 554.00K | 19.65% |
Net change in cash | 2.64M | 130.34% |
Free cash flow | -8.81M | -25.53% |
About
Founded
2018
Headquarters
Website
Employees
30
